Thai workplace app Eko announced that it has acquired local AI chatbot firm ConvoLab for an eight-figure-dollar sum while Singapore-based health-tech startup Plano has received an undisclosed sum from Japan’s Santen Pharmaceutical.
Thailand’s Eko acquires chatbot platform ConvoLab
Thai workplace app Eko announced that it has acquired local AI chatbot firm ConvoLab for an eight-figure-dollar sum.
Eko also launched its parent company, Amity, which will focus on helping organizations, teams, and people to benefit from new mobile technologies and digitization, according to the company’s announcement.
ConvoLab’s acquisition, completed through a mix of stock and cash, was finalised ahead of Amity’s launch.
Amity plans to invest heavily in AI and work automation and believed chatbots will be one of the main mediums in which AI will be able to assist humans in the workplace.
Singapore’s health-tech startup Plano receives investment from Santen
Singapore-based health-tech startup Plano has received an undisclosed sum from Japanese company Santen Pharmaceutical as part of a strategic alliance between the two firms, according to an announcement.
Launched in 2017, Plano is an eyecare-focused health tech company launched in 2017, founded by Associate Professor Mohamed Dirani. It is the first spin-off from the Singapore Eye Research Institute (SERI) – Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator Programme.
The company claims that its application has been adopted by more than 250,000 households.